Merck Buys VelosBio for $2.75 Billion
Sunday, November 15, 2020
Photo courtesy of VelosBio. VelosBio’s licensed its antibody-drug conjugate ROR1 from UCSD cancer researcher Thomas Kipps.
Pharmaceutical giant Merck, will pay $2...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know